Deerfield commits up to $130M to commercialize drug discovery at the University of Michigan

press
Written By Jessica Sagers

December 18, 2019

ANN ARBOR—A new partnership between the University of Michigan and health care investment firm Deerfield Management Co. will create a company to commercialize therapeutic projects that hold promise in solving unmet medical needs.

U-M and Deerfield on Wednesday announced the launch of Great Lakes Discoveries LLC. Deerfield has committed up to $130 million over the next decade to invest in biomedical research at U-M with the aim of developing potentially life-saving drugs and disease treatments.

Jessica Sagers
Previous

Great Lakes Discovery to Facilitate University of Michigan Researcher to Pursue a Therapeutic Treatment for Systemic Inflammation